US EditionFACT FOCUS: Trump blames other countries for high US drug prices. Experts say it’s not their fault
- On Monday, President Donald Trump signed an executive order aimed at lowering U.S. Prescription drug costs by linking prices to those in other developed countries.
- The order establishes a 'most favored nation' pricing model, triggered if drugmakers do not voluntarily reduce prices within 30 days, but its impact on private insurance beneficiaries remains unclear.
- A 2024 RAND report analyzing data from 2022 revealed that drug prices in the U.S. Were nearly three times greater than those in 33 similar nations, with the U.S. Responsible for 62% of $989 billion in pharmaceutical spending despite representing just 24% of the total drug volume.
- Experts attribute high U.S. Drug prices mainly to the fragmented negotiation process involving insurers and pharmacy benefit managers, and emphasize structural differences compared to other countries.
- Experts and scholars state that blaming foreign nations for U.S. Drug prices is misleading, and increasing bargaining power could help reduce costs amid for-profit pharmaceutical companies pushing higher list prices.
62 Articles
62 Articles
Press-Telegram
FACT FOCUS: Trump blames other countries for high US drug prices. Experts say it’s not their fault
By MELISSA GOLDIN President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making the comments Monday when signing an executive order intended to lower their cost. Related Articles Americans are divided over DEI programs on college campuses, poll finds Trump’s sanctions on ICC prosecutor have halted tribunal’s work Older people in crossha…
'It does nothing': Trump's 'surreal parallel universe' plan burned down on MSNBC
According to financial analyst Steve Rattner, Donald Trump's executive order demanding prescription drug prices must go down was a nothing-burger that is not worth the paper it was written on.Appearing on MSNBC's "Morning Joe," Rattner pointed to the signing by Trump, who called it one of the most "...
Pharmaceuticals in the face of Trump’s scourge: which companies best face the price cut of medicines
The pharmaceutical companies lost on Monday part of the bullish feast that left on the Stock Exchange the tariff truce agreed between the United States and China. They started the day with sharp falls, up to 8% for Novo Nordisk, after Donald Trump announced the signing of an executive order to lower the price of the drugs paid by the US federal government by 30% to 80%, but those declines remained almost nothing at the end of the session. The qu…
Trump declared war on drug dealers: His policies are killing drug users
Trump sold his border and tariff policies in part as a way to reduce the death of drug users in the US. Yet his domestic drug policies are putting users' lives at risk. He may have created MAGA, but in this duplicity, Trump is a traditional Republican....
Time Magazine
DNyuzWill Trump’s Executive Order Lower Prescription Drug Prices?
The cost of prescription drugs in the U.S. has long outpaced that of peer nations, a dynamic driven by a combination of regulatory gaps, market forces, and lobbying pressure. Now, President Donald Trump is once again trying to tackle the issue—this time through an Executive Order that aims to pressure pharmaceutical companies to voluntarily lower their prices. [time-brightcove not-tgx=”true”] On Monday, President Donald Trump signed the Executiv…
Associated Press News
FACT FOCUS: Trump blames other countries for high US drug prices. Experts say it's not their fault
This is misleading. Prices for most prescription drugs — unbranded generics are the exception — are higher in the U.S. than they are in other high-income countries.
Coverage Details
Bias Distribution
- 45% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
